CARDIOPROTECTION BY ACE-INHIBITORS IN MYOCARDIAL ISCHAEMIA REPERFUSION - THE IMPORTANCE OF BRADYKININ/

Citation
G. Heusch et al., CARDIOPROTECTION BY ACE-INHIBITORS IN MYOCARDIAL ISCHAEMIA REPERFUSION - THE IMPORTANCE OF BRADYKININ/, Drugs, 54, 1997, pp. 31-41
Citations number
100
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
DrugsACNP
ISSN journal
00126667
Volume
54
Year of publication
1997
Supplement
5
Pages
31 - 41
Database
ISI
SICI code
0012-6667(1997)54:<31:CBAIMI>2.0.ZU;2-V
Abstract
Myocardial ischaemia, when severe and sustained for more than 40 minut es, results in irreversible damage, i.e. myocardial infarction. Howeve r, with early reperfusion, damage is reversible. Complete recovery of contractile function requires some time, despite fully or almost fully restored blood flow. This phenomenon has been termed myocardial stunn ing. There is experimental evidence showing that angiotensin convertin g enzyme (ACE) inhibitors limit the development of infarct size, reduc e the incidence of ischaemic and reperfusion arrhythmias, and enhance the recovery of contractile function of stunned myocardium. These card ioprotective effects of ACE inhibitors are mediated by an attenuated d egradation of bradykinin.